EFFECT OF AC-3579, A DIAZAFLUORANTHEN DERIVATIVE, ON MURINE LEUKEMIA P388 AND L1210 .1. IN-VIVO STUDY

被引：4

作者：

HILDEBRAND, J

THYS, O

ATASSI, G

DEBUSSCHER, L

TAGNON, HJ

机构：

[1] UNIV LIBRE BRUSSELS, SERV MED INTERN, 1000 BRUSSELS, BELGIUM

[2] UNIV LIBRE BRUSSELS, CTR TUMEURS, INST JULES BORDET, LAB INVEST CLIN, 1000 BRUSSELS, BELGIUM

[3] UNIV LIBRE BRUSSELS, LAB ANAT PATHOL & MICROSCOPIE ELECTR, 1000 BRUSSELS, BELGIUM

[4] UNIV LIBRE BRUSSELS, LAB MED EXPTL, 1000 BRUSSELS, BELGIUM

来源：

EUROPEAN JOURNAL OF CANCER | 1973年 / 9卷 / 09期

关键词：

D O I：

10.1016/0014-2964(73)90005-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：635 / +

页数：1

共 44 条

[31] INVITRO ANTIPROLIFERATIVE ACTIVITY OF 2'-(2-HYDROXYPHENYL)-2'-THIAZOLINE-4'-CARBOXYLIC ACID AND ITS METHYL-ESTER ON L1210 AND P388 MURINE NEOPLASMS
ELLIOT, GT
KELLY, KF
BONNA, RL
WARDLAW, TR
BURNS, ER
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 21 (03) : 233 - 236
[32] COMBINATION CHEMOTHERAPY AGAINST L1210 AND P388 LEUKEMIA - MELPHALAN-5-FLUOROURACIL, VINCRISTINE-ADRIAMYCIN, MECHLORETHAMINE-HYDROXY-UREA, AND METHOTREXATE-MITOMYCIN C
MABEL, JA
MERKER, PC
WODINSKY, I
GERAN, RI
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 144 - 144
[33] INVIVO ANTITUMOR-ACTIVITY OF 6-BENZYL-1,3-BENZODIOXOLE DERIVATIVES AGAINST THE P388, L1210, B-16, AND M5076 MURINE MODELS
JURD, L
NARAYANAN, VL
PAULL, KD
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (10) : 1752 - 1756
[34] PREPARATION OF COMPLEXES OF LOW-DENSITY LIPOPROTEINS (LDL) AND 9-METHOXY ELLIPTICINE AND THEIR CYTO-TOXIC EFFECT INVITRO ON 2 MURINE LYMPHOCYTIC TUMOR-CELL LINES, L1210 AND P388
SAMADIBABOLI, M
FAVRE, G
BLANCY, E
SOULA, G
BULLETIN DU CANCER, 1988, 75 (07) : 672 - 673
[35] ENHANCEMENT OF CYTOGENETIC DAMAGE AND OF ANTINEOPLASTIC EFFECT IN LYMPHOID L1210 LEUKEMIA-CELLS TREATED WITH PROSTAGLANDIN-E2 AND CYCLOPHOSPHAMIDE IN-VIVO
MOURELATOS, D
MIOGLOU, E
KRISTI, Z
DOZIVASSILIADES, J
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1995, 326 (01) : 125 - 129
[36] EFFECT OF HOMOHARRINGTONINE ON THE VIABILITY OF MURINE LEUKEMIA P388 CELLS RESISTANT TO EITHER ADRIAMYCIN, VINCRISTINE, OR 1-BETA-D-ARABINOFURANOSYLCYTOSINE
WILKOFF, LJ
DULMADGE, EA
LASTER, WR
GRISWOLD, DP
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (03) : 145 - 150
[37] AMINO ACID CONFERRED RESISTANCE TO MELPHALAN .1. STRUCTURE-ACTIVITY RELATIONSHIP IN CULTURED MURINE L1210 LEUKEMIA-CELLS
VISTICA, DT
TOAL, JN
RABINOVITZ, M
CANCER TREATMENT REPORTS, 1976, 60 (09): : 1363 - 1367
[38] PREPARATION OF LOW-DENSITY LIPOPROTEIN-9-METHOXYELLIPTICIN COMPLEX AND ITS CYTO-TOXIC EFFECT AGAINST L1210 AND P388 LEUKEMIC-CELLS INVITRO
SAMADIBABOLI, M
FAVRE, G
BLANCY, E
SOULA, G
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02): : 233 - 241
[39] IN-VIVO DNA-DAMAGE INDUCED BY A NEW SUGAR DERIVATIVE OF N-NITROSOUREA CRC-0510375 ARANOSE IN SENSITIVE AND RESISTANT TO THE DRUG L1210 LEUKEMIA-CELLS
GOODTZOVA, KV
KUKUSHKINA, GV
ELKSNE, SJ
KALISTRATOV, AV
GORBACHEVA, LB
EXPERIMENTAL ONCOLOGY, 1995, 17 (02): : 99 - 104
[40] EVALUATION OF COMBINATION CHEMOTHERAPY - 1-BETA-D-ARABINOFURANOSYL-CYSTOSINE (ARA-C) AND 1-FORMYLISOQUINOLINE-THIOSEMICARBAZONE (IQ-1) ON LEUKEMIA L1210 CELLS IN-VIVO AND IN CULTURE
GRINDEY, GB
MIHICH, E
NICHOL, CA
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1970, 11 : 32 - &

← 1 2 3 4 5 →